Bharat Biotech’s Covaxin approved for kids aged 2-18 yrs by Subject Expert Committee

New Delhi: Bharat Biotech’s Covaxin approved for kids aged 2-18 yrs by Subject Expert Committee. Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN (BBV152) to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and has provided their positive recommendations.